Sensex 27019.39 151.84 0.57%
Nifty 8083.05 55.35 0.69%
Covidien Plc plans to buy Somanetics Corp. for US$25 a share in cash, according to reports. The deal valued at US$250mn. Covidien said the acquisition would broaden its medical equipment product offerings and create earnings growth over time. The deal values Somanetics at a premium of US$6.10, or 32%, over its closing price of US$18.9 a share on 15th June.
India Infoline Research Team / 08:59, Sep 02, 2014
The indices are expect to open on a positive note. Some profit booking could always set in later in the day.